Literature DB >> 20838940

Assessment of cardiovascular risk.

Marie Therese Cooney1, Helen C Cooney, Alexandra Dudina, Ian M Graham.   

Abstract

Atherosclerotic cardiovascular disease (CVD) is the most common cause of death worldwide. Usually atherosclerosis is caused by the combined effects of multiple risk factors. For this reason, most guidelines on the prevention of CVD stress the assessment of total CVD risk. The most intensive risk factor modification can then be directed towards the individuals who will derive the greatest benefit. To assist the clinician in calculating the effects of these multiple interacting risk factors, a number of risk estimation systems have been developed. This review address several issues regarding total CVD risk assessment: Why should total CVD risk be assessed? What risk estimation systems are available? How well do these systems estimate risk? What are the advantages and disadvantages of the current systems? What are the current limitations of risk estimation systems and how can they be resolved? What new developments have occurred in CVD risk estimation?

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20838940     DOI： 10.1007/s11906-010-0143-1

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


  46 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

Authors:  R B D'Agostino; S Grundy; L M Sullivan; P Wilson
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

3.  Prediction of mortality risk in the elderly.

Authors:  Stefan Störk; Richard A Feelders; Annewieke W van den Beld; Ewout W Steyerberg; Huub F J Savelkoul; Steven W J Lamberts; Diederick E Grobbee; Michiel L Bots
Journal:  Am J Med       Date:  2006-06       Impact factor: 4.965

Review 4.  Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review.

Authors:  P Brindle; A Beswick; T Fahey; S Ebrahim
Journal:  Heart       Date:  2006-04-18       Impact factor: 5.994

5.  European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Authors:  Ian Graham; Dan Atar; Knut Borch-Johnsen; Gudrun Boysen; Gunilla Burell; Renata Cifkova; Jean Dallongeville; Guy De Backer; Shah Ebrahim; Bjørn Gjelsvik; Christoph Herrmann-Lingen; Arno Hoes; Steve Humphries; Mike Knapton; Joep Perk; Silvia G Priori; Kalevi Pyorala; Zeljko Reiner; Luis Ruilope; Susana Sans-Menendez; Wilma Scholte Op Reimer; Peter Weissberg; David Wood; John Yarnell; Jose Luis Zamorano; Edmond Walma; Tony Fitzgerald; Marie Therese Cooney; Alexandra Dudina; Alec Vahanian; John Camm; Raffaele De Caterina; Veronica Dean; Kenneth Dickstein; Christian Funck-Brentano; Gerasimos Filippatos; Irene Hellemans; Steen Dalby Kristensen; Keith McGregor; Udo Sechtem; Sigmund Silber; Michal Tendera; Petr Widimsky; Jóse Luis Zamorano; Attila Altiner; Enzo Bonora; Paul N Durrington; Robert Fagard; Simona Giampaoli; Harry Hemingway; Jan Hakansson; Sverre Erik Kjeldsen; mogens Lytken Larsen; Giuseppe Mancia; Athanasios J Manolis; Kristina Orth-Gomer; Terje Pedersen; Mike Rayner; Lars Ryden; Mario Sammut; Neil Schneiderman; Anton F Stalenhoef; Lale Tokgözoglu; Olov Wiklund; Antonis Zampelas
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2007-09

6.  Cardiovascular risk prediction tools for populations in Asia.

Authors:  F Barzi; A Patel; D Gu; P Sritara; T H Lam; A Rodgers; M Woodward
Journal:  J Epidemiol Community Health       Date:  2007-02       Impact factor: 3.710

Review 7.  Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.

Authors:  Marie Therese Cooney; Alexandra L Dudina; Ian M Graham
Journal:  J Am Coll Cardiol       Date:  2009-09-29       Impact factor: 24.094

8.  Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.

Authors:  Julia Hippisley-Cox; Carol Coupland; Yana Vinogradova; John Robson; Rubin Minhas; Aziz Sheikh; Peter Brindle
Journal:  BMJ       Date:  2008-06-23

9.  General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

Authors:  Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

10.  Estimation of cardiovascular risk: a comparison between the Framingham and the SCORE model in people under 60 years of age.

Authors:  Tjarda Scheltens; W M Monique Verschuren; Hendriek C Boshuizen; Arno W Hoes; Nicolaas P Zuithoff; Michiel L Bots; Diederick E Grobbee
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2008-10
View more
  3 in total

Review 1.  Cardiovascular risk assessment: a global perspective.

Authors:  Dong Zhao; Jing Liu; Wuxiang Xie; Yue Qi
Journal:  Nat Rev Cardiol       Date:  2015-03-10       Impact factor: 32.419

2.  A genome-wide screen for interactions reveals a new locus on 4p15 modifying the effect of waist-to-hip ratio on total cholesterol.

Authors:  Ida Surakka; Aaron Isaacs; Lennart C Karssen; Pirkka-Pekka P Laurila; Rita P S Middelberg; Emmi Tikkanen; Janina S Ried; Claudia Lamina; Massimo Mangino; Wilmar Igl; Jouke-Jan Hottenga; Vasiliki Lagou; Pim van der Harst; Irene Mateo Leach; Tõnu Esko; Zoltán Kutalik; Nicholas W Wainwright; Maksim V Struchalin; Antti-Pekka Sarin; Antti J Kangas; Jorma S Viikari; Markus Perola; Taina Rantanen; Ann-Kristin Petersen; Pasi Soininen; Asa Johansson; Nicole Soranzo; Andrew C Heath; Theodore Papamarkou; Inga Prokopenko; Anke Tönjes; Florian Kronenberg; Angela Döring; Fernando Rivadeneira; Grant W Montgomery; John B Whitfield; Mika Kähönen; Terho Lehtimäki; Nelson B Freimer; Gonneke Willemsen; Eco J C de Geus; Aarno Palotie; Manj S Sandhu; Dawn M Waterworth; Andres Metspalu; Michael Stumvoll; André G Uitterlinden; Antti Jula; Gerjan Navis; Cisca Wijmenga; Bruce H R Wolffenbuttel; Marja-Riitta Taskinen; Mika Ala-Korpela; Jaakko Kaprio; Kirsten O Kyvik; Dorret I Boomsma; Nancy L Pedersen; Ulf Gyllensten; James F Wilson; Igor Rudan; Harry Campbell; Peter P Pramstaller; Tim D Spector; Jacqueline C M Witteman; Johan G Eriksson; Veikko Salomaa; Ben A Oostra; Olli T Raitakari; H-Erich Wichmann; Christian Gieger; Marjo-Riitta Järvelin; Nicholas G Martin; Albert Hofman; Mark I McCarthy; Leena Peltonen; Cornelia M van Duijn; Yurii S Aulchenko; Samuli Ripatti
Journal:  PLoS Genet       Date:  2011-10-20       Impact factor: 5.917

3.  Estimation of the 10-Year Risk of Cardiovascular Diseases: Using the SCORE, WHO/ISH, and Framingham Models in the Shahrekord Cohort Study in Southwestern Iran.

Authors:  Pooneh Samaniyan Bavarsad; Solieman Kheiri; Ali Ahmadi
Journal:  J Tehran Heart Cent       Date:  2020-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.